Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures
Journal of the American Geriatrics Society · 2026-06 · 74 (6) · 1647-1657
DOI: 10.1111/jgs.70444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 16.04.2026. Verfasst von Iva Neupane und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Buprenorphine, Rib Fractures, Analgesics, Opioid, Pain Management. Die Arbeit nennt 18 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Older trauma patients with rib fractures experience significantly higher morbidity and mortality compared to younger individuals. As effective pain control is a foundation of management, older adults present a challenge for clinicians aiming to balance pain control with adverse event risk. Despite the growing utilization of transdermal buprenorphine for acute pain, its effectiveness specifically in older patients with rib fractures remains under explored.
Methods
This retrospective cohort study at a trauma intensive care unit within a Level I trauma center, examined 779 patients aged ≥ 65 years admitted with multiple rib fractures from December 1, 2022 to November 30, 2024. Outcomes were compared between those who received transdermal buprenorphine and those who did not. Primary outcome was oral morphine equivalent consumption. Secondary outcomes included non‐opioid analgesic use, naloxone administration, hospital length of stay (LOS), intensive care unit (ICU) LOS, complications, discharge disposition, in‐hospital mortality, and 30‐day readmission rates.
Results
Seven hundred and eighteen admissions met inclusion criteria, with 16.4% (118) receiving transdermal buprenorphine. They were significantly older (82.0 ± 8.2 vs. 79.5 ± 8.9 years, p = 0.0054) and presented with higher comorbidities (CCI 7.3 ± 4.1 vs. 6.3 ± 3.7; p = 0.0064). Total hospital opioid use did not differ significantly. However, second day post administration opioid requirements were significantly lower in the transdermal buprenorphine group (6.5 ± 17.6 mg vs. 14.8 ± 24.9 mg, adjusted p = 0.0359), as well as overall opioid consumption after patch application (18.1 ± 46.5 mg vs. 73.8 ± 138.5 mg; adjusted p < 0.0001). No differences were observed on days three or four. We report no naloxone use in the transdermal buprenorphine group versus 1.1% in the non‐transdermal buprenorphine group. There were no significant differences in other secondary outcomes.
Conclusion
Older trauma patients with multiple rib fractures treated with transdermal buprenorphine used less opioids and less naloxone during acute pain management without other benefits including LOS and mortality, suggesting a favorable safety and analgesic profile. However, a formal evaluation through a randomized controlled trial is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Department of Trauma and Surgical Critical Care, Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Department of Surgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Department of Pharmacy, Brown University Health, Providence, Rhode Island, USA.
- Department of Hospital Medicine, Internal Medicine, University of Kentucky, Lexington, Kentucky, USA.
- Center of Innovation in Long-Term Services and Supports, Providence Veterans Administration Medical Center, Providence, Rhode Island, USA.
ORCID-Profile: Iva Neupane, Nadia Mujahid, Jessica Arabi, Ashna Rajan, Audrea Bose
Zitieren
APA
Neupane, I., Mikolasko, B., Adams, C. A., Monteiro, J. F. G., Mujahid, N., Girouard, L., Arabi, J., Rajan, A., Bose, A., Lueckel, S., McNicoll, L., & Gravenstein, S. (2026). Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures. Journal of the American Geriatrics Society, 74(6), 1647-1657. https://doi.org/10.1111/jgs.70444
Vancouver
Neupane I, Mikolasko B, Adams CA, Monteiro JFG, Mujahid N, Girouard L, et al. Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures. Journal of the American Geriatrics Society. 2026;74(6):1647-1657. doi:10.1111/jgs.70444
BibTeX
@article{Neupane2026,
author = {Neupane, Iva and Mikolasko, Brian and Adams, Charles A and Monteiro, Joao Filipe Goncalves and Mujahid, Nadia and Girouard, Linda and Arabi, Jessica and Rajan, Ashna and Bose, Audrea and Lueckel, Stephanie and McNicoll, Lynn and Gravenstein, Stefan},
title = {Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures},
journal = {Journal of the American Geriatrics Society},
year = {2026},
volume = {74},
number = {6},
pages = {1647--1657},
doi = {10.1111/jgs.70444}
}
EUVIMED